Hope Biosciences Shares Promising Topline Results in Multiple Sclerosis
Hope Biosciences, a clinical-stage biotechnology company today shares positive top-line results of a Phase II clinical trial.
top of page
We are developing stem cell therapies that are
Safe
We develop autologous therapies—from your body to your body. We employ vigorous quality control testing to ensure the highest quality product.
Effective
Our proprietary core technology grows mesenchymal stem cells to unprecedented quantities. Adequate dosages are needed for effective treatments.
Repeatable
Our proprietary stem cell banking technology allows for banked cells to be used repeatedly. Effective treatment of a condition often requires repeated treatment.
Secure
Much of our research is devoted to the science of cell preservation. This step is critical to ensure that the cells banked today can be used in the future.
REGENERATIVE MEDICINE IS THE FUTURE
Our expertise lies in the ability to multiply and bank one's own cells for use in the future. Instead of imagining the potential, we decided to put them to the test.
Trust your health—your cells—to the company determined to make the availability of your cells, a reality.
​
Who we work with:
latest news
bottom of page